Chemoinformaics analysis of 4-Methyleneglutamic acid
| Molecular Weight | 159.141 | nRot | 4 |
| Heavy Atom Molecular Weight | 150.069 | nRig | 3 |
| Exact Molecular Weight | 159.053 | nRing | 0 |
| Solubility: LogS | -1.27 | nHRing | 0 |
| Solubility: LogP | -3.064 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 20.3291 |
| nHD | 3 | BPOL | 10.1949 |
| QED | 0.477 |
| Synth | 3.101 |
| Natural Product Likeliness | 1.651 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.01 |
| HIA | 0.012 |
| CACO-2 | -6.072 |
| MDCK | 0.00561512 |
| BBB | 0.127 |
| PPB | 0.158463 |
| VDSS | 0.348 |
| FU | 0.782904 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.019 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.039 |
| CYP2c9-inh | 0.103 |
| CYP2c9-sub | 0.08 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.135 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.01 |
| CL | 7.031 |
| T12 | 0.76 |
| hERG | 0.013 |
| Ames | 0.031 |
| ROA | 0.036 |
| SkinSen | 0.722 |
| Carcinogencity | 0.075 |
| EI | 0.151 |
| Respiratory | 0.225 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.925411 |